6919 · Caliway Biopharmaceuticals Co Ltd
97.80
TWDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
NT$156.51B
PE
180.80
EV/EBITDA
57.3
DIV Yield
0%
Payout Ratio
0%
MQV Rating
5Very Weak
As at 24/07/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- Consensus Cheap
- HALO 100
- HALO 200
- HALO All
- HALO Consensus Value
- HALO Value
Key Fundamentals
EPS 3 yr Growth
-6.50%
EBITDA Margin
NaN%
Operating Cashflow
-NT$426m
Free Cash Flow Return
-4.50%
ROIC
-3.70%
Interest Coverage
NaN
Quick Ratio
109.60
Performance
52 weeks range
Low 75.1 - 277
Trade Value (12mth)
US$15,110,654.00
1 week
-11.45%
1 month
-3.37%
YTD
-34.53%
1 year
-24.15%
All time high
277.00
Additional Data
Shares Outstanding (Fully Diluted)
1,549m
HALO Sector
Healthcare
Next Company Report Date
02-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
TWD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Weak
Earnings
Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
News & Announcements
No announcements available.
